PMID: 6107677Nov 15, 1980Paper

Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity

Lancet
A J StunkardR O'Brien

Abstract

Behaviour therapy, pharmacotherapy, and a combination of the two were compared in 120 obese women and 14 obese men during six months of treatment for obesity and at one-year follow-up. Patients who received the appetite suppressant fenfluramine lost 14.5 kg and those who received the combined treatment lost 15.3 kg, both significantly more than those who received only behaviour therapy (10.9 kg). One-year follow-up of all living patients who completed treatment showed a striking reversal of these effects: behaviour-therapy patients regained only 1.9 kg, significantly less than pharmacotherapy patients (8.2 kg) and combined-therapy patients (10.7 kg). Weight changes of the 14 men did not differ from those of the women. Although pharmacotherapy produced more rapid initial weight loss than behaviour therapy, it was followed by more rapid weight gain after treatment. Addition of pharmacotherapy apparently compromised the long-term effects of behaviour therapy. Better maintenance of weight loss and lower costs favour behaviour therapy over pharmacotherapy for the treatment of obesity.

References

Jan 1, 1976·Addictive Behaviors·L G Ost, K G Götestam

❮ Previous
Next ❯

Citations

Oct 1, 1995·Journal of Clinical Pharmacology·S MedirattaW H Frishman
Jan 1, 1996·Advances in Health Sciences Education : Theory and Practice·J J Perkins, R W Sanson-Fisher
Mar 1, 1982·Journal of Behavioral Medicine·T P CarmodyJ D Matarazzo
Jan 1, 1984·Behaviour Research and Therapy·P M Dubbert, G T Wilson
Jan 1, 1981·Journal of Psychosomatic Research·A J Stunkard
Aug 1, 1982·Maturitas·F de WaardE A Baanders-van Halewijn
Apr 1, 1990·Journal of Ethnopharmacology·P ParanjpeB Patwardhan
Feb 19, 1983·Lancet·J G DouglasJ F Munro
Sep 1, 1984·Lancet
Jul 1, 1991·Clinical Endocrinology·R T Jung, P Chong
Jul 1, 1991·Medical Education·R W Sanson-FisherJ J Perkins
Oct 24, 1981·British Medical Journal·A GrimsmoC Borchgrevink
Jun 9, 2001·BMJ : British Medical Journal·D Arterburn, P H Noël
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Vincent Setola, Bryan L Roth
Jan 1, 1992·Critical Reviews in Food Science and Nutrition·C M Bergholz
Dec 1, 1984·Controlled Clinical Trials·C L MeinertK Higgins
Jul 1, 1989·The Diabetes Educator·M BernbaumA B Silverberg
Apr 1, 1984·Statistics in Medicine·H J Keselman, J C Keselman
Feb 1, 1982·Klinische Wochenschrift·O I Linet
Mar 20, 2019·Current Obesity Reports·Jena Shaw TronieriAdam Gilden Tsai
Dec 22, 1999·Endocrine Reviews·G A Bray, F L Greenway
Aug 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·E GoodallT Silverstone
Nov 1, 1995·Obesity Research·G A Bray
May 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·R M ManningR W Newton
Jan 29, 2016·Current Obesity Reports·Kelly C AllisonThomas A Wadden
May 1, 1986·Nutrition Reviews·T D BrewertonN E Rosenthal
Dec 12, 2001·Medicine and Science in Sports and Exercise·J M JakicicUNKNOWN American College of Sports Medicine
Oct 1, 1981·Sozial- Und Präventivmedizin·B HochstrasserH P Müller
Mar 1, 1982·British Journal of Clinical Pharmacology·C R Joyce
Jan 1, 1981·Acta Medica Scandinavica·B Hylander, S Rössner
Oct 1, 1982·Postgraduate Medicine·R B FriedmanJ A Reinke
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·R Alemzadeh
Apr 1, 1985·The Medical Journal of Australia·A J Stunkard
Dec 9, 1985·The Medical Journal of Australia·M L Mashford

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.